All In Biotech

Free tool

FAERS Monitor: Fleqsuvy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215602 or its brand name (Fleqsuvy, Baclofen). Reports on generic versions are filed under their own applications.

Reports

85,252

Serious

56,388

66% of reports

Hospitalization

27,995

Death reported

6,381

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue6,301
  • drug ineffective5,648
  • pain5,556
  • fall5,450
  • nausea4,694
  • headache4,446
  • gait disturbance4,135
  • off label use3,872
  • dizziness3,632
  • urinary tract infection3,526
  • asthenia3,445
  • multiple sclerosis relapse3,419
  • muscle spasms3,278
  • diarrhoea3,162
  • vomiting2,873

Reports by year received

View as table
YearReports
2004646
2005757
2006675
2007795
2008886
20091,033
20101,500
20111,738
20122,502
20133,001
20144,251
20155,157
20167,596
20177,023
20187,705
20196,672
20205,778
20215,486
20225,102
20235,675
20244,228
20254,068
20262,975

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,968,907 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple sclerosis relapseSignal3,41912.912.535,769
gait disturbanceSignal4,1355.45.314,734
urinary tract infectionSignal3,5265.25.011,760
muscle spasmsSignal3,2784.54.38,741
fallSignal5,4504.14.012,716
astheniaSignal3,4452.32.22,474
painSignal5,5562.22.23,904
fatigueSignal6,3012.02.03,268
dizziness3,6321.81.71,318
headache4,4461.81.71,477
vomiting2,8731.51.5504
nausea4,6941.51.4718
diarrhoea3,1621.21.2118
off label use3,8721.11.131
drug ineffective5,6481.11.019

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.